SOLENO THERAPEUTICS INC
SLNODrugs in Pipeline
1
Phase 3 Programs
1
Upcoming Catalysts
0
Next Catalyst
None scheduled
Market Overview
Stock performance and key metrics
0 upcoming, 0 past
No catalysts found.
How SLNO's past catalysts played out
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
DCCR | Phase 3 | Prader-Willi Syndrome | - | - |
Frequently asked questions
What is in SOLENO THERAPEUTICS INC's drug pipeline?→
CatalystAlert tracks 1 drug candidate in SOLENO THERAPEUTICS INC's (SLNO) pipeline across Phase 3. Its lead program is DCCR (Phase 3). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is SOLENO THERAPEUTICS INC's next FDA catalyst?→
CatalystAlert tracks every upcoming catalyst for SOLENO THERAPEUTICS INC (SLNO) — PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings — each confidence-rated as confirmed, estimated or AI-detected.
How do I track SLNO biotech catalysts?→
Add SLNO to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow SOLENO THERAPEUTICS INC's live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.